Favorable prognosis after late relapse of Hodgkin's disease

Cancer

Volumn 83, Issue 3, 1998, Pages 560-565

  Garcia Carbonero, R ^a   Paz Ares, L ^a   Arcediano, A ^a   Lahuerta, J ^a   Bartolome, A ^a   Cortes Funes, H ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hodgkin's disease; Late relapse; Prognostic factors; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANIMALS; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SURVIVAL RATE;

EID: 0032147163     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T     Document Type: Article

References (23)

1. Urba JW, Longo DL. Hodgkin's disease. N EngL J Med 1992; 326:678-87.
2. Young RC, Canellos PG, Chabner BA, Hubbard SM, DeVita VT. Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer 1978;42: 1001-7.
3. Rosenberg SA, Kaplan HS. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 1985;11:5-22.
4. Bodis S, Henry-Amar M, Bosq J, Burgers JMV, Mellink WAM, Dietrich PY, et al. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. J Clin Oncol 1993;11:225-32.
5. Herman TS, Hoppe RT, Ronaldson SS, Cox RS, Rosenberg SA, Kaplan HS. Late relapse among patients treated for Hodgkin's disease. Ann Intern Med 1985;102:293-7.
6. Duschene G, Crow J, Ashley S, Brada M, Horwich A. Changing patterns of relapse in Hodgkin's disease. Br J Cancer 1989;60:227-30.
7. Hung SJ, Hung WJ, Anagnostou AA. Recurrence of Hodgkin's disease 29 years later. Cancer 1988;61:186-8.
8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1.
9. Longo DL, Young RC, Wesley M, Hubbard SM, Duffey PL, Jaffe ES, et al. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 1986;4:1295-304.
10. Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy vs. MOPP plus radiotherapy. J Clin Oncol 1987;5:27-37.
11. Klimo P, Connors JM. An update on the Vancouver experience in the management of Hodgkin's disease treated with the MOPP/ABV hybrid program. Semin Hematol 1988;25(2 Suppl):34-40.
12. Bonadonna G, Valagussa P, Santoro A. Alternating noncross resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease: a report of 8-year results. Ann Intern Med 1986;104:739-46.
13. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
15. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
16. Facon T. High incidence of late relapses in advanced Hodgkin's disease among patients treated by chemotherapy alone. Proceedings of the second International Symposium on Hodgkin's disease; October 3-5, 1991. Cologne: International Symposium on Hodgkin's disease, 1991.
17. Burgers JMV, Somers R, Herny-Amar M, Tarayre M, Carde E, Thomas J, et al. Management of relapse and survival in advanced stage Hodgkin's disease: The EORTC Experience. Ann Oncol 1991;2(2 Suppl):63-6.
18. Longo D, Duffey P, Young R, Hubbard SM, Ihde DC, Glatstein E, et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1992;10:210-8.
19. Brierly JD, Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Pintillie M. Late relapse after treatment for clinical stage I and II Hodgkin's disease. Cancer 1997;79:1422-7.
20. Strum SB, Rappaport H. The persistence of Hodgkin's disease in long term survivors. Am J Med 1971;51:222-40.
21. Lym WA, Marcus KE. Glomerulonephritis preceding late relapse of Hodgkin's disease. Postgrad Med J 1988;64:395-7.
22. Bonadonna G, Santoro A, Gianni A, Viviani S, Siena S, Bregni M, et al. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. Ann Oncol 1991;2(1 Suppl):9-16.
23. Cabanillas F, Velasquez WS, Hagemeister FB, McLaughlin P, Redman JR. Clinical, biological and histologic features of late relapses in diffuse large cell lymphoma. Blood 1992;79: 1024-8.